An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Bio-Rad Laboratories, Inc. (NYSE: BIO) will report its financial results for Q4 and full year 2021 on February 10, 2022, after market close. The company will host a conference call at 3 PM PT (6 PM ET) to discuss the results. Investors can listen by calling in or via a live webcast. Bio-Rad is a leader in life science research and clinical diagnostics, with 2020 revenues exceeding $2.5 billion.
Positive
Established company with over 70 years in the industry.
HERCULES, Calif.--(BUSINESS WIRE)--
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the fourth quarter and full year 2021 on Thursday, February 10, 2022, following the close of the market. The company will discuss these results in a conference call scheduled for 3 PM Pacific Time (6 PM Eastern Time) that day.
To listen, call 844-200-6205 within the U.S. or 929-526-1599 outside the U.S., access code: 348449. You may also listen to the conference call live via webcast that is available on the "Investor Relations" section of our website under "Quarterly Results" at www.bio-rad.com. A replay of the webcast will be available for up to a year.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for 70 years, our products advance the discovery process and improve healthcare. Our customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology and pharmaceutical companies, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with more than 7,800 employees worldwide. Bio-Rad had revenues exceeding $2.5 billion in 2020. For more information, please visit www.bio-rad.com.
Investor Contact:
Bio-Rad Laboratories, Inc. Edward Chung, Vice President, Investor Relations
510-741-6104
ir@bio-rad.com
Source: Bio-Rad Laboratories, Inc.
FAQ
When will Bio-Rad report its financial results for Q4 2021?
Bio-Rad will report its financial results on February 10, 2022.
What time is the Bio-Rad conference call for financial results?
The conference call is scheduled for 3 PM Pacific Time (6 PM Eastern Time) on February 10, 2022.
How can I listen to the Bio-Rad financial results call?
You can listen by calling 844-200-6205 within the U.S. or 929-526-1599 outside the U.S., or via a live webcast available on Bio-Rad's Investor Relations page.
What significant revenue did Bio-Rad achieve in 2020?
Bio-Rad reported revenues exceeding $2.5 billion in 2020.
